Head-to-head for moms
Ro vs Hims & Hers
Ro and Hims & Hers both offer GLP-1 telehealth to mothers, but they make different trade-offs on family-budget value, clinical oversight, price and access. Here they are side-by-side on the Editors' Rating — our six-factor rubric for mothers.
Ro
Higher scoreRanked #5 · Grade B
Best for: Mothers who specifically want an FDA-approved brand product with insurance help and are comfortable inside a large, well-funded platform.
Visit RoHims & Hers
Ranked #6 · Grade B
Best for: Mothers who want a familiar, app-driven consumer brand with an explicit women's entrance and a sema price they can see before signing up.
Visit Hims & HersThe verdict
Ro edges out Hims & Hers on the Editors' Rating, 85 to 84 (B vs B). Mothers who specifically want an FDA-approved brand product with insurance help and are comfortable inside a large, well-funded platform.
Hims & Hers is still a genuine option — through its Hers front door, one of the few mass-market brands built around a woman's identity — app-first, nationwide, disclosed sema pricing — though the depth behind the branding is thinner than the marketing suggests. Weigh the six factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Ro | Hims & Hers |
|---|---|---|
| Editors' Rating | 85/100 · B | 84/100 · B |
| Overall rank | #5 | #6 |
| Semaglutide | Not disclosed | $165/mo |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Multi-state | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Yes |
Ro
Ranked #5 · Grade B
What we like
- Real brand-name (Wegovy/Zepbound) access and serious insurance navigation
- Oral options and a genuinely polished, reliable experience
- Deep clinical infrastructure behind the app
The caveats
- Compounded pricing isn't disclosed up front — a budget you can't preview
- Premium positioning, and brand cash-pay is expensive without coverage
- Big-platform feel; support can be less personal than a small care team
Hims & Hers
Ranked #6 · Grade B
What we like
- Explicit women-focused (Hers) positioning and broad brand trust
- Nationwide, with a slick app and simple onboarding
- Discloses a monthly semaglutide price up front, and offers an oral route
The caveats
- Tirzepatide pricing isn't consistently disclosed
- Limited hormonal or maternal depth behind the branding
- Volume-first model; ongoing clinical touch is light
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes an Editors' Rating. Pricing, states and verification reflect each provider's public disclosures at last review; the Editors' Rating is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Ro and Hims & Hers against other providers we review for mothers.
Or browse the full comparison hub.